ES2125236T3 - Mejoras relativas a la deteccion de virus. - Google Patents

Mejoras relativas a la deteccion de virus.

Info

Publication number
ES2125236T3
ES2125236T3 ES91908087T ES91908087T ES2125236T3 ES 2125236 T3 ES2125236 T3 ES 2125236T3 ES 91908087 T ES91908087 T ES 91908087T ES 91908087 T ES91908087 T ES 91908087T ES 2125236 T3 ES2125236 T3 ES 2125236T3
Authority
ES
Spain
Prior art keywords
virus detection
improvements related
dna
proteins
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908087T
Other languages
English (en)
Inventor
Jane Grundy
Vincent Emery
Paul Griffiths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Free Hospital School of Medicine
Original Assignee
Royal Free Hospital School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Free Hospital School of Medicine filed Critical Royal Free Hospital School of Medicine
Application granted granted Critical
Publication of ES2125236T3 publication Critical patent/ES2125236T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

VARIANTES DEL CITOMEGALOVIRUS HUMANO (CMV) QUE CONTIENEN, AL MENOS, UNA ALTERACION EN LA SECUENCIA DE SU ADN EN LA REGION QUE CODIFICA LOS EPITOPES DE LA GLICOPROTEINA GB. SE PREFIEREN LAS VARIANTES CUYO RESULTADO ES UN CAMBIO PARA LA PROTEINA CODIFICADA POR EL ADN. SE DESCRIBEN VECTORES DE EXPRESION QUE CODIFICAN TALES PROTEINAS ALTERADAS Y ANTICUERPOS PARA LAS PROTEINAS.
ES91908087T 1990-04-11 1991-04-11 Mejoras relativas a la deteccion de virus. Expired - Lifetime ES2125236T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008223A GB9008223D0 (en) 1990-04-11 1990-04-11 Improvements relating to the detection of viruses

Publications (1)

Publication Number Publication Date
ES2125236T3 true ES2125236T3 (es) 1999-03-01

Family

ID=10674284

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908087T Expired - Lifetime ES2125236T3 (es) 1990-04-11 1991-04-11 Mejoras relativas a la deteccion de virus.

Country Status (10)

Country Link
US (2) US5567582A (es)
EP (1) EP0527785B1 (es)
JP (2) JP3140773B2 (es)
AT (1) ATE174056T1 (es)
DE (1) DE69130562T2 (es)
DK (1) DK0527785T3 (es)
ES (1) ES2125236T3 (es)
GB (1) GB9008223D0 (es)
GR (1) GR3029322T3 (es)
WO (1) WO1991015586A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301804A1 (en) * 2002-11-05 2004-06-07 Institut National De La Sante Et De La Recherche Medicale Dc-sign blockers and their use for preventing or treating viral infections.
US7427469B2 (en) * 2002-11-05 2008-09-23 Institut Pasteur Method of treating cytomegalovirus with DC-SIGN blockers
US7272333B2 (en) * 2005-06-30 2007-09-18 Xerox Corporation Image quality measurements using linear array in specular mode
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
DK2352759T3 (en) 2008-07-16 2017-12-18 Inst Res Biomedicine ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUS AND USE THEREOF
EA201270662A1 (ru) 2009-12-23 2013-01-30 4-Антибоди Аг Связывающие элементы для человеческого цитамегаловируса
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
US5124440A (en) * 1986-11-24 1992-06-23 The Childrens Hospital, Inc. Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
DE68929478T2 (de) * 1988-01-29 2004-04-29 Aventis Pasteur Rekombinante CMV-Neutralisierungsproteine
US5547834A (en) * 1988-01-29 1996-08-20 Chiron Corporation Recombinant CMV neutralizing proteins

Also Published As

Publication number Publication date
WO1991015586A1 (en) 1991-10-17
DK0527785T3 (da) 1999-08-16
US5883225A (en) 1999-03-16
EP0527785B1 (en) 1998-12-02
ATE174056T1 (de) 1998-12-15
DE69130562T2 (de) 1999-04-29
US5567582A (en) 1996-10-22
GB9008223D0 (en) 1990-06-13
GR3029322T3 (en) 1999-05-28
JP3141024B2 (ja) 2001-03-05
JPH05506985A (ja) 1993-10-14
JP3140773B2 (ja) 2001-03-05
DE69130562D1 (de) 1999-01-14
JP2000333685A (ja) 2000-12-05
EP0527785A1 (en) 1993-02-24

Similar Documents

Publication Publication Date Title
ATE325882T1 (de) Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind
ES2127829T3 (es) Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
ES2134770T3 (es) Proteinas producidas por los linfocitos humanos, secuencia de adn codante para estas proteinas y aplicaciones farmaceuticas y biologicas.
ATE109795T1 (de) Htlv-iii umhüllende peptiden.
PT584348E (pt) Vacina genetica para virus da imunodeficiencia
ES2125236T3 (es) Mejoras relativas a la deteccion de virus.
DK626486D0 (da) Syntetiske antigener til afslaering af aids-relateret sygdom
DK11789D0 (da) Rekombinante vaccinia-vira
ES2139017T3 (es) Compuestos que inhiben la replicacion del vih.
ES2072900T3 (es) Expresion elevada de proteinas en levadura.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
AR248045A1 (es) Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferencia
DK421687D0 (da) Vektorvirus, der baerer en heterolog dna-sekvens
ES2174835T3 (es) Carboxilasa dependiente de la vitamina k.
ES2087869T3 (es) Proteinas modificadas; interferones alfa y beta modificados, proteinas fosforiladas y analogos, secuencias de adn, y sus aplicaciones.
ES2115622T3 (es) Clones moleculares de hiv-1 y usos de los mismos.
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
AR245957A1 (es) Un dna recombinante que codifica para una proteina recombinante ligada a un soporte y un procedimiento para la fabricacion de la misma.
ITRM920350A0 (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
ATE147100T1 (de) Ehv-4 glykoprotein vazin
KR940003566A (ko) 재조합 아데노바이러스 백신
ATE165369T1 (de) Antikoagulierende peptide
ES2146193T1 (es) Proteinas del virus del arrugado de las hojas de la vid (tipo 2) y sus usos.
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 527785

Country of ref document: ES